Related Experiment Video

Updated: Mar 26, 2026

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

10.2K

Glutamate E15 and E171 are Hotspots in p60TRP-Related Cancer

Arne Kutzner1, Klaus Heese2

  • 1a Department of Information Systems , College of Engineering, Hanyang University , Seoul , Republic of Korea.

Cancer Investigation
|February 9, 2016
PubMed

Insights

Researchers identified p60TRP, a GPCR-associated sorting protein, as a potential target for cancer therapeutics. Mutations in specific regions of p60TRP were observed, offering new avenues for drug development against previously "undruggable" Ras-driven cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • RAS proteins are key regulators of cellular signaling, implicated in numerous cancers.
  • RAS signaling is often dysregulated, but RAS proteins themselves are considered

Purpose of the Study:

  • To investigate the role of p60TRP, a GPCR-associated sorting protein, in cancer development.
  • To identify potential therapeutic targets within the RAS signaling pathway.

Main Methods:

  • Analysis of human cancer genome datasets.
  • Identification and characterization of p60TRP mutations.

Main Results:

  • p60TRP was identified as a novel protein associated with GPCR signaling.
  • Specific mutation hotspots (E15 and E171) were identified in p60TRP across various cancer types.
  • These findings suggest p60TRP as a potential therapeutic target.

Conclusions:

  • p60TRP plays a role in cancer and presents a druggable target.
  • Targeting p60TRP mutations could offer new strategies for treating Ras-driven cancers.
Keywords:
BHLHB9CancerGASPGPRASPRanRasp60TRP

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

316
Establishment of a Clinic-based Biorepository07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

7.0K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K